Screener / SEC EDGAR /CIK 0001114483 /10-K filed Feb 23, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Medical Devices

Integer Holdings Corp ITGR

Compare with peers Embed
Cash returned and share count

No buyback or stock pay figures in its 10-K data yet

XBRL, 10-K

Where the cash came from and where it went

FY2025, from the cash flow statement in the 10-K, added up

Operating cash flowDebt raisedCash on hand usedCapital spendingAcquisitionsBuybacksDebt repaidOther, net Operating cash flow: $196.1M Operating cash flow $196.1M Debt raised: $977.5M Debt raised $977.5M Cash on hand used: $29.4M Cash on hand used $29.4M Capital spending: $91.0M Capital spending $91.0M Acquisitions: $178.9M Acquisitions $178.9M Buybacks: $50.0M Buybacks $50.0M Debt repaid: $667.7M Debt repaid $667.7M Other, net: $219.0M Other, net $219.0M

Each number is a line of the cash flow statement as the company tagged it. "Other, net" is what those lines do not cover (investments bought and sold, other financing and investing lines, and exchange rates); Tickdelta does not estimate it.

Where the operating cash went, year by year

FY2016 to FY2025 · cash flow statements, 10-K XBRL

10 years
Operating cash, added up $1.6B 10 fiscal years, FY2016 to FY2025
Reinvested 87% capital spending and acquisitions, as a share of that cash
Returned to owners 3% buybacks and dividends, as a share of that cash
Debt repaid $2.0B gross repayments added up; debt that was refinanced counts each time
Fiscal yearOperating cashCapital spendingAcquisitionsBuybacksDebt repaid
Dec 31, 2025 $196.1M $91.0M$178.9M$50.0M$667.7M
Dec 31, 2024 $205.2M $105.4M$138.5M-$6K
Dec 31, 2023 $180.2M $119.9M$43.6M-$415.9M
Dec 31, 2022 $116.4M $74.7M$126.6M--
Dec 31, 2021 $156.7M $53.5M$218.0M--
Dec 31, 2020 $181.3M $46.8M$5.2M--
Dec 31, 2019 $165.4M $48.2M$15.0M--
Dec 28, 2018 $167.3M $44.9M--$705.5M
Dec 29, 2017 $149.4M $47.3M--$178.6M
Dec 30, 2016 $105.5M $58.6M--$46.0M
Added up$1.6B $690.4M
43% of operating cash
$725.9M
45% of operating cash
$50.0M
3% of operating cash
$2.0B
124% of operating cash

Each bar is one fiscal year; its colours add up to what the cash flow statement says the company spent on each line, and the line across it is that year's operating cash flow. Spending above the line was paid from new debt, shares sold or cash on hand. A bar part links to the 10-K it comes from. A line the company did not report is left out, not estimated, so the shares are of operating cash only and can add up to more or less than 100%. Debt repaid is the gross amount, so refinanced debt is counted each time it is repaid. A reading aid, not a grade: Tickdelta does not say whether a split was good. Banks and insurers are left out.

Buybacks, dividends and share count

Year by year · XBRL, each 10-K

No buyback or share count data in the 10-K XBRL.

Buybacks month by month, and what is left to buy

Share buybacks · 10-Q, Part II Item 2, latest 4 quarters

Still open to buy $100.0M under the programme, end of Apr 2026
Latest month 127,070 shares Apr 2026, average $84.80

“Issuer Purchases of Equity Securities On November 4, 2025, the Company announced that its Board of Directors authorized a new share repurchase program allowing for purchases of up to $200.0 million in the aggregate of outstanding Integer common stock (the “Share Repurchase Program”).”

10-Q, Part II Item 2

“As of October 2, 2026, the dollar value of shares that may yet be purchased under the Share Repurchase Program was $100 million.”

10-Q, Part II Item 2
MonthShares boughtAverage price
Apr 2026 127,070 $84.80
Feb 2026 462,535 $84.80

Shares and average price are the numbers in the 10-Q table, row by row; "shares × price" is our multiplication of the two. A row with a price of "-" is an accelerated repurchase paid up front, where the 10-Q does not give a price yet. A 10-Q that counts shares in millions gives a rounded number, shown as "about". Shares withheld for employees' taxes are not in this table. A month that no 10-Q table gives, or that this page could not read with confidence, is not shown.

What the 10-Ks show for each CEO's years

Each CEO's years · the CEO of each fiscal year as named in the proxy's pay versus performance table

Joseph W. Dziedzic, Payman Khales

FY2025 · 1 year in the table
Operating cash flow
$196.1M
Capital spending
$91.0M
Acquisitions
$178.9M
Buybacks
$50.0M
Stock-based pay
$23.2M
Diluted shares since FY2024
-0.2%
Revenue since FY2024
+8%
Debt since FY2024
+$195.0M
CEO pay (reported)
$11.9M
The proxy that names the CEO

Joseph W. Dziedzic

FY2021 to FY2024 · 4 years in the table
Operating cash flow
$658.5M
Capital spending
$353.5M
Acquisitions
$526.8M
Buybacks
$0
Stock-based pay
$85.3M
Diluted shares since FY2020
+7.7%
Revenue since FY2020
+60%
Debt since FY2020
+$258.9M
CEO pay (reported)
$35.8M
The proxy that names the CEO

Sources

The cash flow statement, dividends per share and diluted share count in each 10-K's XBRL; Part II Item 2 of each 10-Q for monthly buybacks; offering prospectuses (S-3, 424B) for new shares; Form D data sets for private raises.

Also

CEO pay: what the CEO was paid over the same years.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ITGR/export.csv") into a cell.

Next:CEO pay
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.